event

Financing and Dilution in Start-Up Companies: Bench2Market Talks

Primary tabs

Bench2Market Talk Series

Financing and Dilution in Start-Up Companies

Register Here

Join us on June 2nd to learn business strategies around equity negations, fundraising, and dilution for life science start-ups. 

Speaker, James Stubbs, PhD has over 20 years of commercialization experience and has held senior executive roles in five medical device startups including founder, CEO, CTO, CSO and VP of Scientific Affairs.  Since 2005 he has contributed to four successful startup exits valued at over $500M. James is currently teaching medical device design and Capstone in the Biomedical Engineering Department at Georgia Tech and is an active private investor.

This event is the final session in the current Bench2Market Talks series which was created to provide commercialization guidance to the university research community. Stay tuned for additional information on your next series starting in the fall of 2021. For more details visit https://biolocity.gatech.edu/bench2market/.

Groups

Status

  • Workflow Status:Published
  • Created By:Christina Wessels
  • Created:05/12/2021
  • Modified By:Christina Wessels
  • Modified:05/12/2021